Future Science Group

Vision in Scientific and Medical Publishing

  • Subjects
    • Biomedicine
    • Environmental Science
    • Molecular Medicine
    • Cardiology
    • Immunology & Infection
    • Neurology
    • Clinical Medicine
    • Medicinal Chemistry
    • Oncology
    • Drug R&D
  • Services
    • Journal information and publication guidanceFor Researchers
    • Flexible and measurable access optionsFor Librarians
    • Subject-specific resources for the medical communityFor Clinicians
    • Market insight and communications supportFor Professionals
  • Publications
    • High-quality reviews and researchJournals
    • DRM-free, 24/7 accesseBooks
    • Series in our eBook collectioneBook Series
  • FSG Connect
    • On-demand and interactiveWebinars
    • Peer-curated online networksWebsites
    • Social Networks
  • About
    • Our background and missionAbout Future Science Group
    • Who’s who at FSGThe Team
    • Vacancies at FSGCareers
  • News
  • Email
  • Facebook
  • Google+
  • Linkedin
  • Twitter

Emerging Therapeutics for Melanoma

£155

Emerging Therapeutics for Melanoma

Edited by Francesco M Marincola, Paolo A Ascierto & John M Kirkwood

Category: Oncology Tag: 2012
  • Description

Description

Published January 2012

ISBN: 978-1-78084-032-1

Understanding of the biology of melanoma has increased substantially during the past two decades, with consequent advances in therapeutic approaches and overall disease management. This book addresses diagnosis, prevention, prognosis, treatment and follow up in melanoma. In twelve chapters from international experts, the book provides a comprehensive overview of the current status of understanding and management of melanoma, including discussion of current limitations and suggestions for modification of strategies that could help current promising concepts to yield success in the clinic.

Chapters
  1. Melanoma pathophysiology and drug targets
    Giuseppe Palmieri, Carla Rozzo, Giusy Gentilcore & Paolo Antonio Ascierto
  2. Melanoma classification, diagnosis and staging
    Mohammed Kashani-Sabet
  3. Melanoma prevention
    Pamela B Cassidy, Douglas Grossman & Sancy A Leachman
  4. Surgical treatment of melanoma: from excision to sentinel node biopsy
    Nicola Mozzillo & Corrado Caracò
  5. Adjuvant therapy in melanoma
    Diwakar Davar, Ahmad A Tarhini & John M Kirkwood
  6. Immunostimulatory monoclonal antibodies for melanoma treatment
    Miguel Fernandez de Sanmamed, Jose L Perez-Gracia, Salvador Martín-Algarra & Ignacio Melero
  7. New signal transduction inhibitors
    Keith T Flaherty
  8. Melanoma vaccines in development
    Ruggero Ridolfi, Laura Ridolfi, Stefania VL Nicoletti & Massimo Guidoboni
  9. Melanoma and biomarkers of immunoresponsiveness: predicting the clinical outcome of immunotherapy
    Davide Bedognetti, Ena Wang, Mario Roberto Sertoli & Francesco M Marincola
  10. Uveal melanoma
    Paola Queirolo, Graziano Caltabiano & Francesco Spagnolo
  11. Management of melanoma brain metastases in the era of targeted therapies Daniela Gonsalves Shapiro, Michael T Shapiro & Wolfram E Samlowski
  12. Which therapy for which patient?
    Antoni Ribas

Related products

  • Advances in Bone Metastasis Management

    £155
    Add to cart
  • Cancer Cachexia

    £155
    Add to cart
  • Advances in the Treatment of Chronic Myeloid Leukemia

    £155
    Add to cart
  • Complex General Surgical Oncology: a Case-Based Approach (Vol 2)

    £155
    Add to cart

Connect

  • Join on LinkedIn
  • Follow on Twitter
  • Join on Facebook
  • Join on Google+

Links

  • Submit a Manuscript
  • Open Access
  • Permissions
  • Reprints
  • Advertising & Sponsorship
  • Subscriptions & Access
  • Other Sites from FSG
  • Pay Your Invoice

Contact

Future Science Group
Unitec House
2 Albert Place
London N3 1QB
United Kingdom

Email: info@future-science-group.com
Tel: +44 (0)20 8371 6090

All rights reserved · Copyright © 2018 - Future Science Group · Cookie Policy · Privacy Policy · Terms and Conditions

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.Accept Cookie Policy